G2 - Discovery based biotechnology company, specialising in the development of monoclonal antibody based pharmaceuticals
About G2 People Partnering News Contact

G2 is a privately funded biotechnology company developing and commercialising novel antibody based therapies in inflammation and cancer. The company is based at the Garvan Institute of Medical Research, one of the largest medical research institutes in Australia.



© G2 Therapies Pty Ltd 2008-2016